JPH10504027A - NMDA拮抗物質としての4−ヒドロキシ−3−フェニル−インデノ(1,2−b)ピリジン−2(1H)−オン誘導体類 - Google Patents
NMDA拮抗物質としての4−ヒドロキシ−3−フェニル−インデノ(1,2−b)ピリジン−2(1H)−オン誘導体類Info
- Publication number
- JPH10504027A JPH10504027A JP8504757A JP50475796A JPH10504027A JP H10504027 A JPH10504027 A JP H10504027A JP 8504757 A JP8504757 A JP 8504757A JP 50475796 A JP50475796 A JP 50475796A JP H10504027 A JPH10504027 A JP H10504027A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- alkyl
- atom
- alk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR94/08999 | 1994-07-20 | ||
FR9408999A FR2722786B1 (fr) | 1994-07-20 | 1994-07-20 | Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant |
PCT/FR1995/000952 WO1996002536A1 (fr) | 1994-07-20 | 1995-07-17 | Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one comme nmda antagonistes |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10504027A true JPH10504027A (ja) | 1998-04-14 |
Family
ID=9465588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8504757A Pending JPH10504027A (ja) | 1994-07-20 | 1995-07-17 | NMDA拮抗物質としての4−ヒドロキシ−3−フェニル−インデノ(1,2−b)ピリジン−2(1H)−オン誘導体類 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0772612A1 (xx) |
JP (1) | JPH10504027A (xx) |
AU (1) | AU2984695A (xx) |
FR (1) | FR2722786B1 (xx) |
WO (1) | WO1996002536A1 (xx) |
ZA (1) | ZA955942B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030082982A (ko) * | 2001-03-14 | 2003-10-23 | 그뤼넨탈 게엠베하 | 치환된 피라졸로피리미딘 및 티아졸로피리미딘 |
WO2015088564A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds |
WO2015088565A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA903588B (en) * | 1989-05-16 | 1991-02-27 | Merrell Dow Pharma | Excitatory amino acid antagonists |
GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
-
1994
- 1994-07-20 FR FR9408999A patent/FR2722786B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-17 JP JP8504757A patent/JPH10504027A/ja active Pending
- 1995-07-17 AU AU29846/95A patent/AU2984695A/en not_active Abandoned
- 1995-07-17 EP EP95925892A patent/EP0772612A1/fr not_active Withdrawn
- 1995-07-17 WO PCT/FR1995/000952 patent/WO1996002536A1/fr not_active Application Discontinuation
- 1995-07-17 ZA ZA955942A patent/ZA955942B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996002536A1 (fr) | 1996-02-01 |
EP0772612A1 (fr) | 1997-05-14 |
AU2984695A (en) | 1996-02-16 |
FR2722786A1 (fr) | 1996-01-26 |
FR2722786B1 (fr) | 1996-08-23 |
ZA955942B (en) | 1996-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5922716A (en) | 5H-indeno 1,2-b!pyrazine-2,3-dione derivatives, their preparation and medicinal products containing them | |
JP2009520685A (ja) | 化合物およびそれらの使用iv | |
US5672705A (en) | Imidazo (1,2-A)pyrazine-4-one derivatives/useful as antagonists of AMPA and NMDA receptors | |
JP3004566B2 (ja) | 新規な(チア)シクロアルキル〔b〕インドール類、それらの製造法及びそれらを含む医薬組成物 | |
EP1177195A1 (fr) | 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES ET/OU -5-THIONES INHIBITRICES DE PHOSPHODIESTERASES IV | |
EP2364298B1 (en) | Quinolone compound and pharmaceutical composition | |
US5777114A (en) | Spiro heterocycle-imidazo 1,2-a!indeno 1,2-e!pyrazine!-4'-ones, preparation thereof and drugs containing same | |
JPH09500873A (ja) | イミダゾ[1,2−a]ピラジン−4−オンの誘導体、それらの製造およびそれらを含有する薬物 | |
JP2003535089A (ja) | 1,4−ジアザビシクロ[3.2.2]ノナン−フェニルイソオキサゾール誘導体、その製法と治療用途 | |
US5789406A (en) | Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them | |
US5807859A (en) | Imidazo (1,2-A)-Indeno (1,2-E) pyrazin-4-one derivatives and pharmaceutical compositions containing same | |
JPH09510730A (ja) | イミダゾ[1,2−a]ピラジン−4−オン誘導体、それらの製造及びそれを含む薬剤 | |
CA2146152A1 (fr) | Derives de 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur preparation et les medicaments les contenant | |
JP2007297411A (ja) | イミダゾ[1,2−a]インデノ[1,2−e]ピラジン−2−カルボン酸の誘導体、その製造およびそれを含む薬物 | |
FR2743365A1 (fr) | Derives de 5h,10h-imidazo(1,2-a)indolo(3,2-e)pyrazine-4-one, leur preparation et les medicaments les contenant | |
JPH10504027A (ja) | NMDA拮抗物質としての4−ヒドロキシ−3−フェニル−インデノ(1,2−b)ピリジン−2(1H)−オン誘導体類 | |
JPH08507303A (ja) | 非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用 | |
KR100557804B1 (ko) | 인돌로모르피난유도체및뇌장해치료·예방제 | |
JP5769504B2 (ja) | 医薬 | |
JPH07500571A (ja) | Pcpレセプター・リガンドおよびその用途 | |
JP2002529470A (ja) | 縮合ピリダジノン化合物 | |
JPH09502711A (ja) | 3,4−ジヒドロ−2h−1,2,4−ベンゾチアジアジン1,1−ジオキシド−3−カルボン酸の誘導体、それらの製造及びそれらを含む薬剤 | |
JP2002518490A (ja) | Cns−疾病の処置のためのdfp−結合部位の配位子としての新規な2−アミノカルボニル−5(2h)−イソキサゾロン類 | |
JPH05213885A (ja) | デカヒドロキノリンの新規な誘導体、それらの製造法、製造中間体、それらの薬剤としての用途及びそれらを含有する組成物 |